Cargando…
Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status
Following the success of cancer immunotherapy using large molecules against immune checkpoint inhibitors, the concept of using small molecules to interfere with intracellular negative regulators of anti-tumor immune responses has emerged in recent years. The main targets for small molecule drugs cur...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644399/ https://www.ncbi.nlm.nih.gov/pubmed/38022587 http://dx.doi.org/10.3389/fimmu.2023.1297175 |